clodronic acid has been researched along with Cholera Infantum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asunmaa, K; Auriola, S; Mönkkönen, H; Mönkkönen, J; Niemi, R; Törmälehto, S; Vepsäläinen, J | 1 |
| Atula, S; Kanis, J; McCloskey, E; Nevalainen, J; Paterson, A; Powles, T | 1 |
1 trial(s) available for clodronic acid and Cholera Infantum
| Article | Year |
|---|---|
Extended safety profile of oral clodronate after long-term use in primary breast cancer patients.
Topics: Administration, Oral; Analysis of Variance; Breast Neoplasms; Clodronic Acid; Confidence Intervals; Double-Blind Method; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Proportional Hazards Models; Time | 2003 |
1 other study(ies) available for clodronic acid and Cholera Infantum
| Article | Year |
|---|---|
Cellular uptake and metabolism of clodronate and its derivatives in Caco-2 cells: a possible correlation with bisphosphonate-induced gastrointestinal side-effects.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Caco-2 Cells; Calcium; Cell Division; Cell Membrane Permeability; Cell Survival; Clodronic Acid; Gastrointestinal Diseases; Humans | 2003 |